U.S. flag

An official website of the United States government

NM_000249.4(MLH1):c.2172del (p.Leu724fs) AND Hereditary cancer-predisposing syndrome

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Mar 16, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002432758.2

Allele description [Variation Report for NM_000249.4(MLH1):c.2172del (p.Leu724fs)]

NM_000249.4(MLH1):c.2172del (p.Leu724fs)

Gene:
MLH1:mutL homolog 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
3p22.2
Genomic location:
Preferred name:
NM_000249.4(MLH1):c.2172del (p.Leu724fs)
HGVS:
  • NC_000003.12:g.37050554del
  • NG_007109.2:g.62205del
  • NM_000249.4:c.2172delMANE SELECT
  • NM_001167617.3:c.1878del
  • NM_001167618.3:c.1449del
  • NM_001167619.3:c.1449del
  • NM_001258271.2:c.1965del
  • NM_001258273.2:c.1449del
  • NM_001258274.3:c.1449del
  • NM_001354615.2:c.1449del
  • NM_001354616.2:c.1449del
  • NM_001354617.2:c.1449del
  • NM_001354618.2:c.1449del
  • NM_001354619.2:c.1449del
  • NM_001354620.2:c.1878del
  • NM_001354621.2:c.1149del
  • NM_001354622.2:c.1149del
  • NM_001354623.2:c.1149del
  • NM_001354624.2:c.1098del
  • NM_001354625.2:c.1098del
  • NM_001354626.2:c.1098del
  • NM_001354627.2:c.1098del
  • NM_001354628.2:c.2079del
  • NM_001354629.2:c.2073del
  • NM_001354630.2:c.2007del
  • NP_000240.1:p.Leu724Phefs
  • NP_000240.1:p.Leu724fs
  • NP_001161089.1:p.Leu626fs
  • NP_001161090.1:p.Leu483fs
  • NP_001161091.1:p.Leu483fs
  • NP_001245200.1:p.Leu655fs
  • NP_001245202.1:p.Leu483fs
  • NP_001245203.1:p.Leu483fs
  • NP_001341544.1:p.Leu483fs
  • NP_001341545.1:p.Leu483fs
  • NP_001341546.1:p.Leu483fs
  • NP_001341547.1:p.Leu483fs
  • NP_001341548.1:p.Leu483fs
  • NP_001341549.1:p.Leu626fs
  • NP_001341550.1:p.Leu383fs
  • NP_001341551.1:p.Leu383fs
  • NP_001341552.1:p.Leu383fs
  • NP_001341553.1:p.Leu366fs
  • NP_001341554.1:p.Leu366fs
  • NP_001341555.1:p.Leu366fs
  • NP_001341556.1:p.Leu366fs
  • NP_001341557.1:p.Leu693fs
  • NP_001341558.1:p.Leu691fs
  • NP_001341559.1:p.Leu669fs
  • LRG_216t1:c.2172del
  • LRG_216:g.62205del
  • LRG_216p1:p.Leu724Phefs
  • NC_000003.11:g.37092045del
  • NM_000249.3:c.2172delG
Protein change:
L366fs
Molecular consequence:
  • NM_000249.4:c.2172del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001167617.3:c.1878del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001167618.3:c.1449del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001167619.3:c.1449del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001258271.2:c.1965del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001258273.2:c.1449del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001258274.3:c.1449del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354615.2:c.1449del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354616.2:c.1449del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354617.2:c.1449del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354618.2:c.1449del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354619.2:c.1449del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354620.2:c.1878del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354621.2:c.1149del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354622.2:c.1149del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354623.2:c.1149del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354624.2:c.1098del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354625.2:c.1098del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354626.2:c.1098del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354627.2:c.1098del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354628.2:c.2079del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354629.2:c.2073del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354630.2:c.2007del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002731407Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely pathogenic
(Mar 16, 2018)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Ambry Genetics, SCV002731407.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The c.2172delG variant, located in coding exon 19 of the MLH1 gene, results from a deletion of one nucleotide at nucleotide position 2172, causing a translational frameshift with a predicted alternate stop codon (p.L724Ffs*59). Frameshifts are typically deleterious in nature; however, this frameshift occurs at the 3' terminus of MLH1 , is not expected to trigger nonsense-mediated mRNA decay, and results in the elongation of the protein by 25 amino acids. Structural analysis shows that this alteration perturbs a known functional domain responsible for binding to PMS2 and removes a cysteine residue shown to be involved in metal binding as part of a functional domain in PMS2 (Mohd AB et al. DNA Repair (Amst.) 2006 Mar;5(3):347-61; Smith CE et al. PLoS Genet. 2013 Oct;9(10):e1003869). Based on the majority of available evidence to date, this variant is likely to be pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024